We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Warns Wyeth Over Effexor XR Promotional Piece
FDA Warns Wyeth Over Effexor XR Promotional Piece
December 21, 2007
A Wyeth professional journal advertisement for antidepressant Effexor XR made unsubstantiated superiority claims, minimized the risks associated with the drug and overstated its efficacy, according to an FDA warning letter.